Apr 30, 2010
2nd Circuit Affirms Decision Favoring Drug Companies on ‘Pay to Delay’ Settlements
A federal appeals court on Thursday upheld summary judgment granted to drug companies sued for violating antitrust laws through so-called “pay-for-delay” patent settlements.